+1 888-880-9539Search News by Tag: immunotherapy
73 news stories found
Press Release
November 22, 2025
Alfa Cytology today unveils its innovative endogenous T-cell engagement system (ETES™) platform.
Read Press Release
Press Release
September 19, 2025
Creative Biolabs has unparalleled experience in immunotherapy modeling and offers a full suite of services that address every facet of CAR-T development.
Read Press Release
Press Release
August 22, 2025
As the global oncology fraternity embraces increasingly smarter cell engineering, Creative Biolabs is redefining what is possible in the fight against cancer.
Read Press Release
Press Release
July 29, 2025
Join Creative Biolabs on August 22 for a live webinar introducing tumoroid-on-a-chip—an advanced 3D organoid model designed to enhance immunotherapy screening.
Read Press Release
Press Release
July 23, 2025
Creative Biolabs delivers key solutions focused on Fc engineering services for effector function stimulation, complement activation, aglycosylation, and effector function inhibition.
Read Press Release
Press Release
June 24, 2025
With mRNA's star power surging from vaccines to gene therapy to precision medicine, the biotech innovator Creative Biolabs is unlocking next-gen solutions to fast-track "impossible" medical breakthroughs.
Read Press Release
Press Release
May 13, 2025
Creative Biolabs made waves the first week of May with a trio of high-impact announcements: commanding attention at the 23rd BioPharma Drug Discovery Nexus Conference, launching its 2025 scholarship program, and previewing a groundbreaking webinar.
Read Press Release
Press Release
April 25, 2025
As an expert in cellular therapy, Creative Biolabs possesses extensive experience in developing CIK cell therapy solutions for cancer treatment research.
Read Press Release
Press Release
April 8, 2025
$25,000 Grant Awarded to Support Innovative Hepatocellular Carcinoma Studies
Read Press Release
Press Release
April 1, 2025
Creative Biolabs recently announced the services for non-IgG antibody production and purification, covering the three major types: IgE, IgM, and IgA.
Read Press Release
Press Release
March 26, 2025
As a reliable collaborator in immunotherapy research, Creative Biolabs offers a true one-stop TIL therapy development service from research and development commencement to preclinical research.
Read Press Release
Press Release
March 24, 2025
Biotechnology Scholar Advances NASA Science to
"Green" Big Pharma with "528 Frequency" Electroceuticals
Read Press Release
Press Release
March 19, 2025
We will present preclinical data on targeting innate inflammation to prevent pancreatic cancer recurrence, improve complete response and survival rate in chemotherapy-treated mice, and overcome cancer resistance in those treated with immunotherapy.
Read Press Release
Press Release
March 4, 2025
Targeting ER dynamics: a novel strategy for antitumor immunity
Read Press Release
Press Release
February 13, 2025
Alfa Cytology has launched ovarian cancer therapy development services.
Read Press Release
Press Release
January 17, 2025
Immunotherapy holds tremendous promise to address unmet medical needs but brings new complexities to the R&D process. Creative Biolabs dabbles well with scientists for innovating in immunity and developing discoveries for immunotherapy research.
Read Press Release
Press Release
November 7, 2024
Alfa Cytology has introduced its advanced drug development services for brain tumors.
Read Press Release
Press Release
November 7, 2024
Dr. Nicholas Franco Explains the Causes and Evaluation of Blood in the Urine (Hematuria)
Read Press Release
Press Release
October 29, 2024
Salman Fazal, MD, has been recognized as a 2024 Castle Connolly Top Doctor — the first year he has received the prestigious Top Doctor honor.
Read Press Release
Press Release
August 28, 2024
Colorectal cancer, a serious condition affecting the colon or rectum, ranks among the most common cancers worldwide, posing significant risks of severe illness and mortality.
Read Press Release